Real-time enrollment status for this non-small cell lung cancer clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 11:44 PM UTC
| NCT Number | NCT04928846 |
| Recruiting Status | Recruiting |
| Condition | Non-Small Cell Lung Cancer |
| Phase | PHASE3 |
| Target Enrollment | 768 participants |
| Active Locations | 50 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | October 5, 2026 (1 week ago) |
As of October 16, 2026: Clinical trial NCT04928846 is currently recruiting participants. This phase3 study for non-small cell lung cancer is actively seeking new participants at 50 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04928846 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 50 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04928846 was last updated 1 week ago (October 5, 2026). HelloStudys verifies this status automatically.